The Case for CAR-T and AL Amyloidosis
Potential Curative Treatment In the quest for more effective treatments for AL Amyloidosis, CAR-T therapy stands out as a beacon of hope. Immix Biopharma’s pioneering efforts in this field have already shown promising results. Among the 13 patients treated with their innovative NXC-201 therapy, two have demonstrated remarkable outcomes, surviving for nearly two years post-treatment. […]